Stella Pharma Corporation (TYO:4888)
Japan flag Japan · Delayed Price · Currency is JPY
431.00
-1.00 (-0.23%)
Nov 18, 2026, 10:15 AM JST

Stella Pharma Balance Sheet

Millions JPY. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
3,8092,8233,2062,0522,7103,276
Short-Term Investments
---300--
Cash & Short-Term Investments
3,8092,8233,2062,3522,7103,276
Cash Growth
36.18%-11.95%36.31%-13.21%-17.28%161.87%
Accounts Receivable
9167714765916
Receivables
9167714765916
Inventory
1,3471,2951,2301,116940773
Prepaid Expenses
586649403936
Other Current Assets
8510244454474
Total Current Assets
5,3904,3535,2433,6293,7924,175
Property, Plant & Equipment
4247668110292
Long-Term Investments
48435757371382
Other Intangible Assets
394249526168
Other Long-Term Assets
-12131
Total Assets
5,5194,4865,4173,8204,3294,718

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
77-22754948
Accrued Expenses
1287462
Current Portion of Long-Term Debt
158158158160160160
Current Income Taxes Payable
808319721220292
Other Current Liabilities
20106446
Total Current Liabilities
347259390455421308
Long-Term Debt
7015886087739331,093
Pension & Post-Retirement Benefits
625959534751
Other Long-Term Liabilities
1,1311,1541,153163176187
Total Liabilities
2,2412,0602,2101,4441,5771,639

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
3,5142,8592,8592,9383,3003,808
Additional Paid-In Capital
1,0033484891952201,908
Retained Earnings
-1,250-780-140-763-778-2,636
Comprehensive Income & Other
11-1-1610-1
Shareholders' Equity
3,2782,4263,2072,3762,7523,079
Total Liabilities & Equity
5,5194,4865,4173,8204,3294,718

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
8597467669331,0931,253
Net Cash (Debt)
2,9502,0772,4401,4191,6172,023
Net Cash Growth
39.74%-14.88%71.95%-12.25%-20.07%-
Net Cash Per Share
84.6761.0573.1045.8156.0072.04
Filing Date Shares Outstanding
36.3634.0234.0231.2229.4828.65
Total Common Shares Outstanding
36.3634.0234.0231.2229.4828.65
Working Capital
5,0434,0944,8533,1743,3713,867
Book Value Per Share
90.1571.3194.2776.1093.35107.48
Tangible Book Value
3,2392,3843,1582,3242,6913,011
Tangible Book Value Per Share
89.0870.0792.8374.4391.28105.10